What are the effects of discontinuing Mounjaro?

Discontinuing Mounjaro, a medication generically known as tirzepatide used primarily for the treatment of type 2 diabetes, can lead to a resurgence of elevated blood sugar levels, as the drug is meant to enhance insulin secretion and suppress glucagon production in response to food intake. As with any medication that regulates glucose metabolism, cessation might increase the risk of diabetes-related complications if not replaced by another effective treatment or counterbalanced by dietary and lifestyle modifications. Patients might also experience weight gain after stopping tirzepatide, considering its role in reducing appetite and body weight in conjunction with managing diabetes. It is important for individuals to consult healthcare professionals before making changes to their diabetes management plan, including stopping Mounjaro, to ensure that transitions in therapy do not adversely impact their overall health and glycaemic control.